| 产品详情 |
| Edit |   |
|---|
| Product Name | LRIG3, Recombinant, Human (Leucine-rich Repeats and Ig-like domains-3, LIG-3) |
|---|
| Description | Purity ≥ 95% as determined by SDS-PAGE and visualized by silver stain. LRIG3 (leucine-rich repeats and Ig-like domains-3) is a 140 kD type I transmembrane glycoprotein member of the mammalian LRIG glycoprotein family. This family contains three members who share 45-50% amino acid (aa) identity. 1 All members contain at least fifteen LRRs, accompanied by two flanking cysteine-rich regions, and three C2-type Ig-like domains in their extracellular domains (ECD). 1 LRIG3 mRNA is widely expressed, with highest levels in stomach, skin, thyroid and small intestine. 1 Human LRIG3 is synthesized as an 1120 amino acid (aa) precursor. It contains a 24 aa signal sequence, a 786 aa ECD, a 21 aa transmembrane sequence, and a 289 aa intracellular region. One splice variant exists that has a 19 aa substitution for the first 79 aa of the standard (or long) form. This substitution appears to encode an alternate signal sequence, resulting in a mature protein that lacks the first and part of the second LR |
|---|
| Size | 50ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | SwissProt: Q6UXM1 |
|---|
| Catalog # | L4488-50 |
|---|
| Price | |
|---|
| Order / More Info | LRIG3, Recombinant, Human (Leucine-rich Repeats and Ig-like domains-3, LIG-3) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|